Rothamsted Research has agreed an exclusive global, commercial licence to a US business for its genetically engineered Camelina sativa variety adapted to produce omega-3 oils for use in aquafeed, petfood and human nutrition. The...
Commercial agreement for Rothamsted’s gene-edited Camelina
read more
